These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 961381)

  • 21. Quantitative evaluation of Al maltolate-induced neurodegeneration with subsequent Al removal by desferrioxamine treatment.
    Huang Y; Savory J; Herman MM; Nicholson JR; Reyes MR; Boyd JC; Wills MR
    Neurotoxicology; 1995; 16(2):291-6. PubMed ID: 7566688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminum neurotoxicity in the absence of neurofibrillary degeneration in CA1 hippocampal pyramidal neurons in vitro.
    Farnell BJ; De Boni U; Crapper McLachlan DR
    Exp Neurol; 1982 Nov; 78(2):241-58. PubMed ID: 7140895
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study on the experimentally produced changes in the neurofibrils in animals, with special reference to electron microscopy findings].
    Ikuta F; Oyanagi S; Tanaka M
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):897-907. PubMed ID: 4980044
    [No Abstract]   [Full Text] [Related]  

  • 24. EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION 2. ELECTRON MICROSCOPY, PHOSPHATASE HISTOCHEMISTRY AND ELECTRON PROBE ANALYSIS.
    TERRY RD; PENA C
    J Neuropathol Exp Neurol; 1965 Apr; 24():200-10. PubMed ID: 14280497
    [No Abstract]   [Full Text] [Related]  

  • 25. Aluminum-induced dendritic pathology revisited: cytochemical and electron microscopic studies of rabbit cortical pyramidal neurons.
    Forbes MS; Ghribi O; Herman MM; Savory J
    Ann Clin Lab Sci; 2002; 32(1):75-86. PubMed ID: 11848622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal gene expression in aluminum-induced neurofibrillary pathology: an in situ hybridization study.
    Chambers CB; Muma NA
    Neurotoxicology; 1997; 18(1):77-88. PubMed ID: 9215990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observations on axoplasmic transport in rabbits with aluminum-induced neurofibrillary tangles.
    Liwnicz BH; Kristensson K; Wiśniewski HM; Shelanski ML; Terry RD
    Brain Res; 1974 Nov; 80(3):413-20. PubMed ID: 4138808
    [No Abstract]   [Full Text] [Related]  

  • 28. Subacute fatal aluminum encephalopathy after reconstructive otoneurosurgery: a case report.
    Reusche E; Pilz P; Oberascher G; Lindner B; Egensperger R; Gloeckner K; Trinka E; Iglseder B
    Hum Pathol; 2001 Oct; 32(10):1136-40. PubMed ID: 11679949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration.
    Crapper DR; Krishnan SS; Dalton AJ
    Science; 1973 May; 180(4085):511-3. PubMed ID: 4735595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative immunocytochemical characterization of neurofibrillary tangles in experimental maytansine and aluminum encephalopathies.
    Ghetti B; Gambetti P
    Brain Res; 1983 Oct; 276(2):388-93. PubMed ID: 6354362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial reversal of aluminium-induced neurofibrillary degeneration by desferrioxamine in adult male rabbits.
    Savory J; Herman MM; Erasmus RT; Boyd JC; Wills MR
    Neuropathol Appl Neurobiol; 1994 Feb; 20(1):31-7. PubMed ID: 8208339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofibrillary accumulation in a puppy.
    de Lahunta A; Shively JN
    Cornell Vet; 1975 Apr; 65(2):240-7. PubMed ID: 1126171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aluminum inhibition of ADP-ribosylation in vivo and in vitro.
    McLachlan DR; Dam TV; Farnell BJ; Lewis PN
    Neurobehav Toxicol Teratol; 1983; 5(6):645-7. PubMed ID: 6422319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration.
    Crapper DR; Krishnan SS; Dalton AJ
    Trans Am Neurol Assoc; 1973; 98():17-20. PubMed ID: 4784929
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of aluminum in the etiopathogenesis of neurological disturbances].
    Kulczycki J
    Rocz Panstw Zakl Hig; 1993; 44(1):49-53. PubMed ID: 8235342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventral root axonopathy and its relation to the neurofibrillary degeneration of lower motor neurons in aluminum-induced encephalomyelopathy.
    Triarhou LC; Norton J; Bugiani O; Ghetti B
    Neuropathol Appl Neurobiol; 1985; 11(6):407-30. PubMed ID: 4094647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topography and dynamics of neurofibrillar degeneration in aluminum encephalopathy.
    Wiśniewski H; Narkiewicz O; Wiśniewska K
    Acta Neuropathol; 1967 Oct; 9(2):127-33. PubMed ID: 6055788
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurofibrillary pathology.
    Wiśniewski H; Terry RD; Hirano A
    J Neuropathol Exp Neurol; 1970 Apr; 29(2):163-76. PubMed ID: 5435819
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative toxicity of intracerebroventricular and subcutaneous aluminum in the rabbit.
    Forrester TM; Yokel RA
    Neurotoxicology; 1985; 6(3):71-80. PubMed ID: 4047517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.